Page last updated: 2024-10-30

metformin and Foreign-Body Reaction

metformin has been researched along with Foreign-Body Reaction in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Foreign-Body Reaction: Chronic inflammation and granuloma formation around irritating foreign bodies.

Research Excerpts

ExcerptRelevanceReference
"Metformin treatment attenuated the main components of the fibrovascular tissue, wet weight, vascularization (Hb content), macrophage recruitment (NAG activity), collagen deposition and the levels of transforming growth factor (TGF-beta1) intraimplant."1.36Metformin inhibits inflammatory angiogenesis in a murine sponge model. ( Amaral, LS; Andrade, SP; Belo, AV; Campos, PR; Cota, BD; Gomes, MA; Paiva, AM; Rocha, MA; Silva, JH; Tafuri, LS; Xavier, DO, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xavier, DO1
Amaral, LS1
Gomes, MA1
Rocha, MA1
Campos, PR1
Cota, BD1
Tafuri, LS1
Paiva, AM1
Silva, JH1
Andrade, SP1
Belo, AV1

Other Studies

1 other study available for metformin and Foreign-Body Reaction

ArticleYear
Metformin inhibits inflammatory angiogenesis in a murine sponge model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2010, Volume: 64, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Chemokine CCL2; Chemotaxis, Leukocyte; C

2010